Bookbuilding IPO | ₹30 Cr | Listed at NSE SME | Thu, Jun 18, 2026 - Mon, Jun 22, 2026
| Category | QIB | NII | Retail | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | Above ₹10L | Below ₹10L | Total NII | |||
| Allocation (No. of shares) | 2,73,600 | 4,09,800 | 6,83,400 | 1,38,000 | 69,000 | 2,07,000 | 4,81,200 | 13,71,600 |
| Allotment price (₹) | 208 | 208 | 208 | 208 | 208 | 208 | 208 | 208 |
| No. of applications | 85 | 4 | 89 | 16,545 | 15,251 | 31,796 | 1,58,284 | 1,90,169 |
| No. of shares applied | 5,33,95,800 | 4,56,400 | 5,38,52,200 | 9,27,72,000 | 3,09,55,200 | 12,37,27,200 | 18,99,40,800 | 36,75,20,200 |
| Amount collected (₹ Cr.) | 1,110.63 Cr | 9.49 Cr | 1,120.13 Cr | 1,929.66 Cr | 643.87 Cr | 2,573.53 Cr | 3,950.77 Cr | 7,644.42 Cr |
| No. of times subscribed | 195.16 | 1.11 | 78.80 | 672.26 | 448.63 | 597.72 | 394.72 | 267.95 |
| No. of shares allotted | 2,73,600 | 4,09,800 | 6,83,400 | 1,38,000 | 69,000 | 2,07,000 | 4,81,200 | 13,71,600 |
| Amount allotted (₹ Cr.) | 5.69 Cr | 8.52 Cr | 14.21 Cr | 2.87 Cr | 1.44 Cr | 4.31 Cr | 10.01 Cr | 28.53 Cr |
| No. of allottees | 74 | 4 | 78 | 76 | 38 | 114 | 401 | 593 |
Avience Biomedicals IPO is a public issue of 0.14 Cr equity shares. The issue offers 0.05 Cr shares to retail investors, 0.07 Cr shares to qualified institutional buyers, and 0.02 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| Market Maker | 82,200 | 1.71 | 5.65% |
| QIB | 6,83,400 | 14.21 | 47.01% |
| Anchor | 4,09,800 | 8.52 | 28.19% |
| QIB (Ex Anchor) | 2,73,600 | 5.69 | 18.82% |
| NII* | 2,07,000 | 4.31 | 14.24% |
| bNII (> ₹10L) | 1,38,000 | 2.87 | 9.49% |
| sNII (< ₹10L) | 69,000 | 1.44 | 4.75% |
| Retail | 4,81,200 | 10.01 | 33.10% |
| Total | 14,53,800 | 30.24 | 100% |
A total of 4,09,800 shares at a price of Rs 208 per share will be allotted to the anchor investors.
| Bid Date | Jun 17, 2026 |
| Price | ₹208.00 |
| % of QIBs | 59.96% |
| Shares Locked (30 Days) | 2,04,900 |
| Shares Locked (90 Days) | 2,04,900 |
| # | Anchor | Group Entity | Shares Allotted | Amt (₹ cr.) | % Allocated | % Allotment of Issue |
|---|---|---|---|---|---|---|
| 1 | SANSHI FUND-I | SANSHI | 1,44,600 | 3.01 | 35.29 | 9.95 |
| 2 | MERU INVESTMENT FUND PCC-CELL 1 | MERU INVESTMENT | 1,20,600 | 2.51 | 29.43 | 8.30 |
| 3 | FORTUNE HANDS GROWTH FUND-FORTUNE HANDS GROWTH FUND SCHEME I | FORTUNE HANDS | 96,000 | 2.00 | 23.43 | 6.60 |
| 4 | SHINE STAR BUILD-CAP PVT.LTD. | SHINE STAR | 48,600 | 1.01 | 11.86 | 3.34 |
| 4,09,800 | 8.52 | 100 | 28.19 | |||
📊 Historic report - IPOs Anchor Investors Investment & Performance
The Avience Biomedicals IPO is subscribed 270.19x as of Jun 22, 2026 18:55.
| Investor Category | Subscription (times) |
|---|---|
| Qualified Institutional | 196.77x |
| Non Institutional | 597.23x |
| Retail Individual | 401.36x |
| Total Subscription | 270.19x |
An investor can apply in Avience Biomedicals IPO online via bank (using ASBA) or the broker (using UPI). The Avience Biomedicals IPO shares are offered online only.
The Avience Biomedicals IPO is subscribed 270.19x times as of Jun 22, 2026 18:55.
The Avience Biomedicals IPO allotment status is expected on or around Tuesday, June 23, 2026. Visit Avience Biomedicals IPO allotment status to check.
The Avience Biomedicals IPO listing date is June 25, 2026. The equity share of Avience Biomedicals IPO will list on NSE SME.
Visit Avience Biomedicals IPO subscription status page for real-time bidding information about Avience Biomedicals IPO.
| IPO opens On | Thursday, June 18, 2026 |
| IPO Closes On | Monday, June 22, 2026 |
| Finalisation of Basis of Allotment | Tuesday, June 23, 2026 |
| Initiation of Refunds | Wednesday, June 24, 2026 |
| Credit of Shares to Demat Account | Wednesday, June 24, 2026 |
| IPO Listing Date | Thursday, June 25, 2026 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |
